RECRUITINGOBSERVATIONAL
Left Atrial Posterior Wall and Mitral Isthmus PF Ablation in Non-Paroxysmal AF Patients
The Acute Efficacy and Safety of Left Atrial Posterior Wall and Mitral Isthmus Ablation in Patients With Non-Paroxysmal Atrial Fibrillation
About This Trial
An observational study evaluating efficacy and safety of the Varipulse catheter in pulsed-field ablation of atrial fibrillation
Who May Be Eligible (Plain English)
Who May Qualify:
1. non-paroxysmal atrial fibrillation
2. an indication for catheter ablation according current guidelines
3. willingness to sign informed content.
Who Should NOT Join This Trial:
1. hematological disorders that can be associated with spontaneous hemolysis
2. chronic kidney disease stage 3 or worse
3. previous left atrial ablation (either using pulsed-field or radiofrequency energy)
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
1. non-paroxysmal atrial fibrillation
2. an indication for catheter ablation according current guidelines
3. willingness to sign informed content.
Exclusion Criteria:
1. hematological disorders that can be associated with spontaneous hemolysis
2. chronic kidney disease stage 3 or worse
3. previous left atrial ablation (either using pulsed-field or radiofrequency energy)
Treatments Being Tested
PROCEDURE
pulsed-field ablation
PVI + PW ablation
Locations (1)
University Hospital Kralovske Vinohrady
Prague, Czechia